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Hybrid materials have an immense potential for applications in a variety of advanced 
technologies, both as structural materials, as well as functional materials in biomedical 
applications. The sustainable development of hybrid materials is moving towards the 
use of green chemistry and clean technologies, namely by the use of natural polymers, 
sol-gel processes, ionic liquids (ILs) and supercritical fluids.  
In this work chitin-based hybrid 3D structures were prepared by particle agglomeration 
associating the use of an IL and a sol-gel process. Bioactive particles were produced 
dissolving chitin in an IL and precipitating the solution in a bath containing 
tetraethylorthosilicate/water/ethanol/hydrochloric acid.  Particle agglomeration was 
promoted by critical point drying as particles were loaded and pressed in a mould 
together with a gellan gum solution which enhanced the agglomeration and provided 
mechanical strength to the system. At the same time it is possible to impregnate the 
particles with an active compound. Ibuprofen was chosen as a model drug and 
impregnation was successfully achieved. Chitin-based materials were characterized in 
terms of their morphological and mechanical properties, sustained release ability, 
bioactivity and biocompatibility. The findings suggest that this strategy is feasible and 
advantageous to process hybrid chitin 3D matrices with both functional and structural 
characteristics that make then suitable for regenerative medicine applications.  
 
 
